SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-036836
Filing Date
2022-12-30
Accepted
2022-12-29 20:10:01
Documents
16
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 20132
2 ex-1.htm EX-1 35269
3 ex-1_001.jpg GRAPHIC 3323
4 ex-2.htm EX-2 3095
5 ex-2_001.jpg GRAPHIC 303599
6 ex-2_002.jpg GRAPHIC 301545
7 ex-3.htm EX-3 616464
8 ex-3_001.jpg GRAPHIC 3800
9 ex-3_002.jpg GRAPHIC 3802
10 ex-3_003.jpg GRAPHIC 3799
11 ex-4.htm EX-4 2478
12 ex-4_001.jpg GRAPHIC 287993
13 ex-4_002.jpg GRAPHIC 148662
14 ex-5.htm EX-5 1797
15 ex-5_001.jpg GRAPHIC 367183
16 ex-5_002.jpg GRAPHIC 303452
  Complete submission text file 0001493152-22-036836.txt   3059888
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 221499991
SIC: 2834 Pharmaceutical Preparations